Trial · NCT00991276
Participant flow90
How many started, completed or left each group, period by period.
1 to 20 of 90
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| First Intervention Period | STARTED | Placebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg | 15 | |
| First Intervention Period | STARTED | Pramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo | 13 | |
| First Intervention Period | STARTED | Pregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg | 14 | |
| First Intervention Period | STARTED | Pregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo | 15 | |
| First Intervention Period | STARTED | Placebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg | 15 | |
| First Intervention Period | STARTED | Pramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg | 13 | |
| First Intervention Period | COMPLETED | Placebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg | 15 | |
| First Intervention Period | COMPLETED | Pramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo | 10 | |
| First Intervention Period | COMPLETED | Pregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg | 14 | |
| First Intervention Period | COMPLETED | Pregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo | 11 | |
| First Intervention Period | COMPLETED | Placebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg | 11 | |
| First Intervention Period | COMPLETED | Pramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg | 12 | |
| First Intervention Period | NOT COMPLETED | Placebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg | 0 | |
| First Intervention Period | NOT COMPLETED | Pramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo | 3 | |
| First Intervention Period | NOT COMPLETED | Pregabalin 300 mg Then Placebo Then Pramipexole 0.5 mg | 0 | |
| First Intervention Period | NOT COMPLETED | Pregabalin 300 mg Then Pramipexole 0.5 mg Then Placebo | 4 | |
| First Intervention Period | NOT COMPLETED | Placebo Then Pregabalin 300 mg Then Pramipexole 0.5 mg | 4 | |
| First Intervention Period | NOT COMPLETED | Pramipexole 0.5 mg Then Placebo Then Pregabalin 300 mg | 1 | |
| Placebo Wash-out Period (7 Days) | STARTED | Placebo Then Pramipexole 0.5 mg Then Pregabalin 300 mg | 15 | |
| Placebo Wash-out Period (7 Days) | STARTED | Pramipexole 0.5 mg Then Pregabalin 300 mg Then Placebo | 10 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00991276/flow